111 Somerset Road, #06-20
TripleOne Somerset
Singapore
As economies around the world are suffering from the impact of Covid-19, businesses are experiencing losses, workers are without jobs, and many face the challenge of a complete upheaval of lifestyle. However, pharmaceutical companies are taking center stage in the Covid-19 fight, and one of these is a Korean conglomerate, SK Group, is seeing growth on the stock market and a new burst of innovation in the infectious disease landscape as the race for treatment approval for a Covid-19 therapy takes off.
SK Group, the 2nd largest group in Korea after Samsung with an annual revenue of $213.6B in 2018, has two arms of pharmaceutical subsidiaries, SK Pharmteco, the pharmaceutical intermediate, and API manufacturer & SK Biopharmaceuticals, the new drug development.
With support from JAS APAC & JAS Worldwide, JAS Korea has become a contracted freight forwarding business partner for SK Biotek as of last December, then after months of implementation period, JAS has been handling various types of Pharmaceutical export shipments by Air & Ocean to additional International Pharmaceutical companies in Europe.
Due to the nature of the cargo, pharmaceutical products, they must be mostly carried by air freight, using special equipment such as dry ice gel/ ice pack, cool/ reefer truck, temperature-controlled storage, and even RKNs which require thorough knowledge and experience to handle such a commodity properly and in a timely manner.
The RKN e1 is a one pallet size container, based on a second-generation active temperature control system and utilizes compressor cooling and electric heating technology, to meet the requirements of the pharmaceutical industry for smaller air shipments.
The RKN e1 container maintains product temperatures in the +2 to +8 °C range, controlled room temperature (+15 to +25 °C) range, JAS Korea has successfully arranged 11 RKN e1 for its door to door delivery to a Spanish Pharmaceutical consignee with Dap term in March, when the Pandemic was in the peak.
SK Pharmteco’s subsidiary, AMPAC is one of the strategic partners to a U.S. public benefit drug manufacturing corporation, which recently received federal government funding of $354 million for advanced manufacturing of America’s most essential medicines at risk of shortage, including those for the COVID-19 response. With its strategic partners, it has initiated manufacturing chemical precursor ingredients, active pharmaceutical ingredients (APIs), and finished dosage forms for over a dozen essential medicines to treat hospitalized patients with COVID-19-related illnesses.
SK Biotek will supply pharmaceutical intermediates to AMPAC and has appointed JAS Korea as the logistics provider for this project. The 1st air shipment was exported to AMPAC in California, USA by suing 5 x RKN e 1 in close cooperation with JAS San Francisco on June 15th, all 5 x RKNs were successfully delivered to AMPAC on the next day. After the ingredient’s analysis main orders will be placed shortly and JAS will continue to handle this business. Next opportunity will be export business out of AMPAC to overseas with the finished products.
JAS Korea is continuing to expand their reputation as the perfect solution for the transportation of pharmaceutical products in the market with these continued efforts excellent team-work. We are sure JAS will be leading the market in a near future.
Tariff regulations are evolving—are you prepared? Watch our exclusive webinar featuring JAS experts Laurie Arnold and Scott Cassell as they break down the latest updates on:
Don’t miss these expert insights—stay informed and stay ahead! Watch now.
Riyadh, Saudi Arabia, March 24, 2025 – JAS and Naqel have signed a Memorandum of Understanding (MoU) to establish a strategic partnership. The partnership will combine Naqel's robust regional network with JAS's global logistics expertise.
Naqel, a subsidiary of Saudi Post Logistics (SPL) provides comprehensive coverage across the GCC region. By partnering with JAS, one of the largest and fastest-growing privately-owned logistics companies, both organizations are well-positioned to support the Kingdom's ambitious plans and strengthen its role as a global logistics hub.
"This partnership marks an exciting milestone for JAS as we expand our presence in Saudi Arabia," said Erwin Wittemaier, Area VP of JAS Middle East. "By combining our global reach with Naqel's deep-rooted regional expertise, we can unlock the full potential of the highly promising Saudi Arabian market."
Dr. Sohail Choudhry, CEO of Naqel Express and Group Chief Commercial Officer of SPL said “This partnership is a bold step towards strengthening our joint position in the region, opening new trade lanes and supporting our SPL Group vision to be a National Logistics champion which reimagines logistics and enhances experiences for our customers”
The MoU was signed by Dr. Adnan Almazrooa, Deputy CEO of Naqel, and Erwin Wittemaier, Area VP of JAS Middle East, in the presence of Dr. Sohail Choudhry, CEO of Naqel, Justin Sloan, Chief of Freight Forwarding at Naqel, and senior leaders from both organizations.
This collaboration aims to develop strategic trade lanes, mitigate supply chain disruptions, and provide multi-modal logistics solutions that drive efficiency and resilience.
By working together, JAS and Naqel will contribute to the Kingdom's Vision 2030 goals of enhancing trade integration, accelerating economic diversification, and fostering sustainable logistics solutions.
------
About JAS
JAS, a global leader in logistics and supply chain solutions, was founded in Milan, Italy, in 1978. Headquartered in Atlanta, Georgia, USA, and supported by 7,000+ team members in more than 100 countries, it builds innovative and sustainable solutions that focus on customer needs and a better future for all. At the heart of JAS's success is its people who deliver customer value. As one of the largest and fastest-growing privately-owned logistics companies, JAS is committed to creating opportunities for our communities, customers, and colleagues to thrive. Together.
About Naqel Express by SPL
NAQEL Express by SPL has been operating in the MENA region since 2005 and is now a proud member of the Saudi Post family. With a presence in 16 countries, it has established itself as a formidable force in logistics. With its unrivaled distribution network and robust fleet, NAQEL seamlessly connects you with even the most remote corners of Saudi Arabia.
NAQEL provides tailored solutions and services such as speedy e-commerce and courier delivery, efficient road transport, smart warehousing and order fulfillment, global air and sea freight forwarding, seamless supply chain solutions, project management, 3PL services, and easy customs clearance. Committed to delivering innovative and sustainable solutions with a focus on environmental responsibility, NAQEL strives to lead the logistics industry towards a greener and more sustainable future.
.jpg)
JAS is excited to announce its participation in LogiPharma 2025, the leading global supply chain conference for the life sciences industry. Taking place from April 8-10 at the Centre de Congrès de Lyon, France, the event brings together key industry leaders to discuss innovations and best practices in logistics.
As a trusted logistics partner, JAS will be exhibiting at Booth 71, where attendees can connect with our experts to explore cutting-edge cold chain solutions, temperature-controlled logistics, and end-to-end supply chain strategies tailored for the industry.
Continuing our tradition, the team will also take part in the LogiPharma 5K Run on Wednesday, April 8, at 7 AM.
Join us at LogiPharma 2025 to discover how we are driving innovation in logistics and ensuring supply chain excellence for our partners around the world.
Our Sites use cookies for analytics purposes. For more information about the cookies we use on our Sites or how you can disable them, please see our Cookie Policy.
.png)